Login to Your Account

Clinic Roundup

Tuesday, January 11, 2011
Cephalon, Inc., of Frazer, Pa., announced positive interim results from an ongoing multicenter Phase II trial of its "off-the-shelf" adult stem cell product Revascor for patients with congestive heart failure.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription